BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26747897)

  • 1. JARID1D Is a Suppressor and Prognostic Marker of Prostate Cancer Invasion and Metastasis.
    Li N; Dhar SS; Chen TY; Kan PY; Wei Y; Kim JH; Chan CH; Lin HK; Hung MC; Lee MG
    Cancer Res; 2016 Feb; 76(4):831-43. PubMed ID: 26747897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZMYND8 Reads the Dual Histone Mark H3K4me1-H3K14ac to Antagonize the Expression of Metastasis-Linked Genes.
    Li N; Li Y; Lv J; Zheng X; Wen H; Shen H; Zhu G; Chen TY; Dhar SS; Kan PY; Wang Z; Shiekhattar R; Shi X; Lan F; Chen K; Li W; Li H; Lee MG
    Mol Cell; 2016 Aug; 63(3):470-84. PubMed ID: 27477906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression.
    Komura K; Jeong SH; Hinohara K; Qu F; Wang X; Hiraki M; Azuma H; Lee GS; Kantoff PW; Sweeney CJ
    Proc Natl Acad Sci U S A; 2016 May; 113(22):6259-64. PubMed ID: 27185910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two Splice Variants of Y Chromosome-Located Lysine-Specific Demethylase 5D Have Distinct Function in Prostate Cancer Cell Line (DU-145).
    Jangravi Z; Tabar MS; Mirzaei M; Parsamatin P; Vakilian H; Alikhani M; Shabani M; Haynes PA; Goodchild AK; Gourabi H; Baharvand H; Salekdeh GH
    J Proteome Res; 2015 Sep; 14(9):3492-502. PubMed ID: 26215926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of Histone Lysine-Specific Demethylase 5D KDM5D) Isoform Expression in Prostate Cancer Cell Lines: a System Approach.
    Jangravi Z; Najafi M; Shabani M
    Iran Biomed J; 2016; 20(2):117-21. PubMed ID: 26728332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D.
    Komura K; Yoshikawa Y; Shimamura T; Chakraborty G; Gerke TA; Hinohara K; Chadalavada K; Jeong SH; Armenia J; Du SY; Mazzu YZ; Taniguchi K; Ibuki N; Meyer CA; Nanjangud GJ; Inamoto T; Lee GM; Mucci LA; Azuma H; Sweeney CJ; Kantoff PW
    J Clin Invest; 2018 Jul; 128(7):2979-2995. PubMed ID: 29863497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
    Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
    J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein.
    Lee MG; Norman J; Shilatifard A; Shiekhattar R
    Cell; 2007 Mar; 128(5):877-87. PubMed ID: 17320162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
    Gao X; Porter AT; Honn KV
    Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer.
    Sinha KM; Bagheri-Yarmand R; Lahiri S; Lu Y; Zhang M; Amra S; Rizvi Y; Wan X; Navone N; Ozpolat B; Logothetis C; Gagel RF; Huard J
    Oncogene; 2019 Jun; 38(25):5038-5049. PubMed ID: 30858546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer.
    Zhang L; Zhang Q; Li L; Wang Z; Ying J; Fan Y; He Q; Lv T; Han W; Li J; Yang Y; Xu B; Wang L; Liu Q; Sun Y; Guo Y; Tao Q; Jin J
    J Mol Med (Berl); 2015 Jun; 93(6):691-701. PubMed ID: 25648635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis.
    Tricarico R; Nicolas E; Hall MJ; Golemis EA
    Clin Cancer Res; 2020 Nov; 26(21):5567-5578. PubMed ID: 32732223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion.
    Björkman M; Östling P; Härmä V; Virtanen J; Mpindi JP; Rantala J; Mirtti T; Vesterinen T; Lundin M; Sankila A; Rannikko A; Kaivanto E; Kohonen P; Kallioniemi O; Nees M
    Oncogene; 2012 Jul; 31(29):3444-56. PubMed ID: 22120715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth.
    Fort RS; Mathó C; Geraldo MV; Ottati MC; Yamashita AS; Saito KC; Leite KRM; Méndez M; Maedo N; Méndez L; Garat B; Kimura ET; Sotelo-Silveira JR; Duhagon MA
    BMC Cancer; 2018 Feb; 18(1):127. PubMed ID: 29394925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.
    Metzger E; Imhof A; Patel D; Kahl P; Hoffmeyer K; Friedrichs N; Müller JM; Greschik H; Kirfel J; Ji S; Kunowska N; Beisenherz-Huss C; Günther T; Buettner R; Schüle R
    Nature; 2010 Apr; 464(7289):792-6. PubMed ID: 20228790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KDM5C is overexpressed in prostate cancer and is a prognostic marker for prostate-specific antigen-relapse following radical prostatectomy.
    Stein J; Majores M; Rohde M; Lim S; Schneider S; Krappe E; Ellinger J; Dietel M; Stephan C; Jung K; Perner S; Kristiansen G; Kirfel J
    Am J Pathol; 2014 Sep; 184(9):2430-7. PubMed ID: 25016185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates epidermal growth factor receptor in prostate cancer.
    Bucay N; Sekhon K; Majid S; Yamamura S; Shahryari V; Tabatabai ZL; Greene K; Tanaka Y; Dahiya R; Deng G; Saini S
    Oncotarget; 2016 Oct; 7(43):70388-70403. PubMed ID: 27611943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IQGAP2, A candidate tumour suppressor of prostate tumorigenesis.
    Xie Y; Yan J; Cutz JC; Rybak AP; He L; Wei F; Kapoor A; Schmidt VA; Tao L; Tang D
    Biochim Biophys Acta; 2012 Jun; 1822(6):875-84. PubMed ID: 22406297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Drg-1 gene suppresses tumor metastasis in prostate cancer.
    Bandyopadhyay S; Pai SK; Gross SC; Hirota S; Hosobe S; Miura K; Saito K; Commes T; Hayashi S; Watabe M; Watabe K
    Cancer Res; 2003 Apr; 63(8):1731-6. PubMed ID: 12702552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.